Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Expensive Performer

1999.6000 -15.80 (-0.78%)

NSE May 15, 2025 10:47 AM

63.23% Gain from 52W Low

Volume: 27,846

Caplin Point Laboratories Ltd.

14 May 2025, 11:04AM

1999.60

-0.78%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Market opens flat, Eicher Motors' Q4 net profit grows 27.3% YoY to Rs 1,362.2 crore

Trendlyne Marketwatch | 15 May 2025, 10:33AM

A car running on flat tires: Pakistan's economy is struggling

The Baseline | 15 May 2025, 09:48AM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets